Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Sequestration Information

    Government notice regarding sequestration information.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Notice of Intent to Issue NOFO DE-FOA-0003649: Leveraging Domestic Infrastructure and Resources to Unleash Alternative Chemicals, Fuels and Feedstocks

    Planned funding would support alternative chemicals, fuels, and feedstocks using domestic biomass, refineries, and pipelines, including hydrogen-natural gas pilots; applications are not yet requested.

    DOE-GFODue Apr 26, 2027

    NOI: PROSPECT Program: Providing Opportunities for Specialized Education in Critical Technologies

    The DOE plans to invest up to $100 million in the PROSPECT Program to boost specialized education and workforce development in critical minerals and materials through academic, industry, and national lab collaboration.

    DOE-GFODue Jan 15, 2027$100,000,000

    Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

    This limited competition funds continued operation of National Cancer Institute biospecimen banks supporting national, early-phase, and experimental cancer clinical trials and translational research.

    HHS-NIH11Due Feb 11, 2027$18,000,000

    Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

    This grant supports multi-year funding for maintaining and staffing Regional Biocontainment Laboratories to enhance infectious disease research, biosafety, and emergency response in the U.S.

    HHS-NIH11Forecasted Sep 30, 2027Forecasted

    Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

    This research will synthesize and test individual forms of the siRNA drug LEQVIO to understand how each form contributes to the drug's overall effectiveness.

    HHS-FDA$300,000Forecasted